From natural products to bioorganic chemistry. What's next?

Journal of Medicinal Chemistry

Volumn 49, Issue 23, 2006, Pages 6627-6634

  Ellestad, George A ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AVOPARCIN; BETA GALACTOSIDASE; CALICHEAMICIN; CINODINE; DNA FRAGMENT; HYPOCHOLESTEROLEMIC AGENT; LL 1271; LL 1272; LL S491; LL Z1640; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; NATURAL PRODUCT; SERINE PROTEINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; ZINOSTATIN;

AROMATIZATION; CARBON NUCLEAR MAGNETIC RESONANCE; CIRCULAR DICHROISM; CONFERENCE PAPER; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG ISOLATION; DRUG POTENCY; DRUG SYNTHESIS; FLUORESCENCE SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDROGEN BOND; MICROCALORIMETRY; NONHUMAN; OXIDATION REDUCTION REACTION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM CHEMISTRY; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE; ULTRAVIOLET SPECTROSCOPY;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTICHOLESTEREMIC AGENTS; ANTIVIRAL AGENTS; AWARDS AND PRIZES; BIOLOGICAL PRODUCTS; CHEMISTRY, PHARMACEUTICAL; CYTOMEGALOVIRUS; DACARBAZINE; ENDOPEPTIDASES; ENEDIYNES; GLYCOPEPTIDES; NAPHTHOQUINONES; SERINE PROTEINASE INHIBITORS; SOCIETIES, SCIENTIFIC; TETRACYCLINES; VIRAL PROTEINS;

EID: 33750995568     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0610494     Document Type: Conference Paper

References (46)

1. Ellestad, G. A.; Kunstmann, M. P.; Whaley, H. A.; Patterson, E. L. Structure of frenolicin. J. Am. Chem. Soc. 1968, 90, 1325-1332.
2. Omura, S.; Tanaka, H.; Okada, Y.; Marumo, H. Isolation and structure of nanaomycin D, an enantiomer of the antibiotic kalafungin. J. Chem. Soc., Chem. Commun. 1976, 320-321.
3. Li, T.-t.; Ellison, R. H. Stereoselective total synthetis of racemic kalafungin and nanaomycin A. J. Am. Chem. Soc. 1978, 100, 6263-6265.
4. Moore, H. W. Bioactivation as a model for drug design bioreductive alkylation. Science 1977, 197, 527-532.
5. Hara, M.; Soga, S.; Shono, K.; Eishima, J.; Mizukami, T. UCF76 compounds, new inhibitors of farnesyltransferase produced by Streptomyces. J. Antibiot. (Tokyo) 2001, 54, 182-186.
6. Armer, R. E.; Dutton, C. J.; Fenner, B. R.; Greenwood, S. D.; Hall, K. T.; Rudge, A. J. Anticoccidial activity of novel semi-synthetic analogues of frenolicin B (part I). Heterocycl. Commun. 1998, 4, 309-315.
7. Holmlund, C. E.; Bohonos, N. Growth inhibition of Tetrahymena pvriformis by 3-dialkylaminoethoxysteroids. Life Sci. 1966, 5, 2133-2139.
8. Holmlund, C. E. Growth inhibition of Tetrahymena pyriformis by a hypocholesteremic compound and the mechanism of its reversal by various lipids. Biochim. Acta 1973, 296, 221-233.
9. Ellestad, G. A.; Evans, R. H., Jr.; Kunstmann, M. P. Terpenoid metabolites from an unidentified Fusarium species. Tetrahedron 1969, 25, 1323-1334.
10. Ellestad, G. A.; Evans, R. H., Jr.; Kunstmann, M. P.; Lancaster, J. E.; Morton, G. O. Structure and chemistry of antibiotic LL-1271α, an antifungal carbon-17 terpene. J. Am. Chem. Soc. 1970, 92, 5483-5489.
11. Ellestad, G. A.; Kunstmann, M. P.; Mirando, P.; Morton, G. O. Structures of fungal diterpene antibiotics LL-491β and γ. J. Am. Chem. Soc. 1972, 94, 6206-6208.
12. Ellestad, G. A.; Lovell, F. M.; Perkinson, N. A.; Hargreaves, R. T.; McGahren, W. J. New zearalenone related macrolides and isocoumarins from and unidentified fungus. J. Org. Chem. 1978, 43, 2339-2343.
13. 2-induced mitogen-activated protein kinase activation by LL-Z1640-2 in CCRF-CEM cells. Eur. J. Pharmacol. 2000, 409, 155.
14. Ellestad, G. A.; Cosulich, D. B.; Broschard, R. W.; Martin, J. H.; Kunstmann, M. P.; Morton, G. O.; Lancaster, J. E.; Fulmor, W.; Lovell, F. M. Glycocinnamoylspermidines. 3. The structures of LL-BM123 β, γ1 and γ2. J. Am. Chem. Soc. 1978, 100, 2515-2524.
15. Osburne, M. S.; Maiese, W. M.; Greenstein, M. In vitro inhibition of bacterial DNA gyrase by cinodine, a glycocinnamoylspermidinine antibiotic. Antimicrob. Agents Chemother. 1990, 34, 1450-1452.
16. Sheldrick, G. M.; Jones, P. G.; Kennard, O.; Williams, D. H.; Smith, G. A. Structure of vancomycin and its complex with acetyl D-alanyl-D-alanine. Nature (London) 1978, 271, 223-225.
17. Ellestad, G. A.; Leese, R. A.; Morton, G. O.; Barbatschi, F.; Gore, W. E.; McGahren, W. J. Avoparcin and epiavoparcin. J. Am. Chem. Soc. 1981, 103, 6522-6524.
18. Greenstein, M.; Wildey, M. J.; Maiese, W. M. The Biochemical Induction Assay and Its Application in the Detection of the Calicheamicins. In Enedivne Antibiotics as Antitumor Agents; Borders. D. B., Doyle, T. W., Eds.; Marcel Dekker, Inc.: New York, 1995; pp 17-27.
19. Fantini, A.; Testa, R. Taxonomy, Fermentation, and Yield Improvement. In Enediyne Antibiotics as Antitumor Agents; Borders, D. B., Doyle, T. W., Eds.; Marcel Dekker, Inc.: New York, 1995; pp 29-47.
20. 1. J. Am. Chem. Soc. 1987, 109, 3466-3468.
21. Hamann, P. R.; Hinman, L. M.; Holander, I.; Beyer, C. F; Lindh, D.; Holcomb, R.; Hallet, W.; Tsou, H.-r.; Upeslacis, J.; Shochat, D.; Mountain, A.; Flowers, D. A.; Bernstein, I. Gemtuzumab ozogamicin, a potent and selective anti-CD-33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker. Bioconjugate Chem. 2002, 13, 47-58.
22. Ellestad, G. A.; Hamann, P. R.; Zein, N.; Morton, G. O.; Siegel, M. M.; Pastel, M.; Borders, D. B.; McGahren, W. J. Reactions of the trisulfide moiety in calicheamcin. Tetrahedron Lett. 1989, 30, 3033-3036.
23. Bergman, R. G. Reactive 1,4-dehydroaromatics. Acc. Chem. Res. 1973, 6, 25-31.
24. 1: an antitumor antibiotic that cleaves double-stranded DNA site specifically. Science (Washington, D.C.) 1988, 240, 1198-1201.
25. Zein, N.; Poncin, M.; Nilikantan, R.; Ellestad, G. A. Calichemicin γ11 and DNA: molecular recognition process responsible for site-specificity. Science (Washington, D.C.) 1989, 244, 697-699.
26. Povirk, L. F.; Goldberg, I. H. Detection of neocarzinostatin chromophore-deoxyribose adducts as exonuclease-resistant sites in defined sequence DNA. Biochemistry 1985, 24, 4035-4040.
27. 1. J. Am. Chem. Soc. 1989, 111, 6888-6889.
28. 1 complex. J. Am. Chem. Soc. 1990, 112, 9669-9670.
29. 1. J. Am. Chem. Soc. 1992, 114, 9200-9202.
30. Kalben, A.; Pal, S.; Andreotti, A. M. H.; Walker, S.; Gange, D.; Biswas, K.; Kahne, D. Calicheamicin-DNA recognition: an analysis of seven different drug-DNA complexes. J. Am. Chem. Soc. 2000, 122, 8403-8412.
31. Paloma, L. G.; Smith, J. A.; Chazin, W. J.; Nicolaou, K. C. Interaction of calicheamicin with duplex DNA: role of the oligosaccharide domain and identification of multiple binding modes. J. Am. Chem. Soc. 1994, 116, 3697-3708.
32. Ikemoto, N.; Kumar, R. A.; Ling, T.; Ellestad, G. A.; Danishefsky, S. K.; Patel, D. J. Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 10506-10510.
33. Salzberg, A. A.; Dedon, P. C. DNA bending is a determinant of calicheamicin target recognition. Biochemistry 2000, 39, 7605-7612.
34. Krishnamurthy, G.; Ding, W.-D.; O'Brian, L.; Ellestad, G. A. Circular dichroism studies of calicheamicin-DNA interaction: evidence for calicheamicin-induced DNA conformational change. Tetrahedron 1994, 50, 1341-1349.
35. Chatterjee, M.; Mah, S.; Tullius, T. A.; Townsend, C. A. Role of the aryl iodide in the sequence-selective cleavage of DNA by calicheamicin: importance of thermodynamic binding vs kinetic activation in the cleavage process. J. Am. Chem. Soc. 1995, 117, 8074-8082.
36. Ding, W.; Pitts, K.; Ellestad, G. A.; Krishnamurhy, G. A reexamination of the circular dichroism of the calicheamicin enediyne/dienone chromophoric interaction. Org. Lett. 2004, 6, 1801-1804.
37. Giorgio, E.; Tanaka, K.; Ding, W.; Krishnamurthy, G.; Pitts, K.; Ellestad, G. A.; Rosini, C.; Berova, N. Theoretical simulation of the electronic circular dichroism spectrum of calicheamcin. Bioorg. Med. Chem. 2005, 13, 5072-5079.
38. McGahren, W. J.; Ding, W.; Ellestad, G. A. Disulfide Calicheamcins and the Chemistry of the Allylic Trisulfide Group. In Enediyne Antibiotics as Antitumor Agents; Borders, D. B., Doyle, T. W., Eds.: Marcel Dekker, Inc.: New York, 1995; pp 75-86.
39. Sum, P.-E.; Lee, V. I.; Testa, R. T.; Hlavka, J. J.; Ellestad, G. A.; Bloom, J. D.; Gluzman, Y.; Tally, F. P. Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. J. Med. Chem. 1994, 37, 184-188.
40. Hillen, W.; Gatz, C.; Altschmied, L.; Schoolmeier, K.; Meier, I. Control of expresson of the Tn10-encoded tetracycline resistance genes. Equilibrium and kinetic investigation of the regulatory actions. J. Mol. Biol. 1983, 169, 707-721.
41. Hinrichs, W.; Kisker, C.; Duvel, M.; Muller, A.; Tovar, K.; Hillen, W.; Saenger, W. Structure of the tet repressor-tetracycline complex and regulation of antibiotic resistance. Science (Washington, D.C.) 1994, 264, 418-420.
42. Baum, E. Z.; Ding, W.; Siegel, M. M.; Hulmes, I.; Bebernitz, G. A.; Sridharan, L.; Tabei, K.; Krishnamurthy, G.; Carofiglio, T.; Groves, J. T.; Bloom, J. D.; DiGrandi, M.; Bradley, M.; Ellestad, G.; Seddon, A. P.; Gluzman, Y. Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation. Biochemistry 1996, 35, 5847-5855.
43. Huang, X.; Aulabaugh, A.; Ding, W.; Kapoor, B.; Alksne, L.; Tabei, K.; Ellestad, G. Kinetic mechanism of Staphyloccocus aureus sortase SrtA. Biochemistry 2003, 42, 11307-11315.
44. Kenny, C. H.; Ding, W.; Kelleher, K.; Benard, S.; Dushin, E. G.; Sutherland, A. G.; Mosyak, L.; Kriz, R.; Ellestad, G. A. Development of a fluorescence polarization assay to screen for inhibitors of the FsZ/ZipA interaction. Anal. Biochem. 2003, 323, 224-233.
45. Landgreth, R.; Herper, M. Germ Warfare. Forbes 2006, June 19, 60-74.
46. Roberts, R. M. Serendipity: Accidental Discoveries in Science; Wiley & Sons: New York, 1989.